Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MCC.0b013e328364d7b1 http://scihub22266oqcxt.onion/10.1097/MCC.0b013e328364d7b1 C4057183!4057183!23995130     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Opin+Crit+Care 2013 ; 19 (5): 417-23 Nephropedia Template TP {{tp|p=23995130|t=2013. Novelties in pharmacological management of cardiopulmonary resuscitation |pdf=|usr=}}{{23995130}} gab.com Text Novelties in pharmacological management of cardiopulmonary resuscitation JO: Curr Opin Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=23995130 #FOAvip Purpose of review: The ultimate goal of cardiopulmonary resuscitation is long-term neurologically intact survival. Despite numerous well designed studies, the medications currently used in advanced cardiac life support have not demonstrated success in this regard. This review describes the novel therapeutics under investigation to improve functional recovery and survival. Recent findings: Whereas current medications focus on achieving return of spontaneous circulation and improved hemodynamics, novel therapies currently in development are focused on improving cellular survival and function by preventing metabolic derangement, protecting mitochondria, and preventing cell death caused by cardiac arrest. Improved cardiac and neurologic function and survival benefits have been observed using animal models of cardiopulmonary arrest. Summary: Although substantial data have shown benefits using robust animal models, further human studies are necessary to investigate the potential long-term benefits of these therapies. Twit Text FOAVip Novelties in pharmacological management of cardiopulmonary resuscitation ????Curr Opin Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=23995130 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=23995130 #FOAvip English Wikipedia <ref>{{Cite pmid|23995130}}</ref> Novelties in pharmacological management of cardiopulmonary resuscitation #MMPMID23995130 Bartos JA; Yannopoulos D Curr Opin Crit Care 2013[Oct]; 19 (5): 417-23 PMID23995130show ga Purpose of review: The ultimate goal of cardiopulmonary resuscitation is long-term neurologically intact survival. Despite numerous well designed studies, the medications currently used in advanced cardiac life support have not demonstrated success in this regard. This review describes the novel therapeutics under investigation to improve functional recovery and survival. Recent findings: Whereas current medications focus on achieving return of spontaneous circulation and improved hemodynamics, novel therapies currently in development are focused on improving cellular survival and function by preventing metabolic derangement, protecting mitochondria, and preventing cell death caused by cardiac arrest. Improved cardiac and neurologic function and survival benefits have been observed using animal models of cardiopulmonary arrest. Summary: Although substantial data have shown benefits using robust animal models, further human studies are necessary to investigate the potential long-term benefits of these therapies. äNovelties in pharmacological management of cardiopulmonary resuscitati(epmc).pdf DeepDyve Pubget Overpricing